YARROW BIOSCIENCE, INC. Debt Securities, Available-for-sale, Unrealized Loss Position
YARROW BIOSCIENCE, INC. (YARW) had Debt Securities, Available-for-sale, Unrealized Loss Position of $5.00 million as of 2025-12-31, per its S-4/A filed 2026-06-03.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2026-06-03
- 2025-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $5.00M.
- 2025-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $17.60M.
- 2024-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $41.60M.
- 2024-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $53.90M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2025-12-31 | $5.00M S-4/A · filed 2026-06-03 |
| 2025-06-30 | $17.60M 10-Q · filed 2025-08-14 |
| 2024-12-31 | $41.60M S-4/A · filed 2026-06-03 |
| 2024-09-30 | $53.90M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $48.50M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $66.90M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $62.60M 10-K · filed 2025-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |